SlideShare ist ein Scribd-Unternehmen logo
1 von 1
Downloaden Sie, um offline zu lesen
Where Attention & Judgment Saves from Catastrophe
Mix up Potential; A Dead End in Multiple Drug Manufacturing Facility
Roohi B. Obaid, R. Ph., M. Phil.
Alumni CDER-USFDA & HPFB-Health Canada
(Karachi the 04th
Mar, 2018)
“Leadership is essential to maintain a
companywide commitment to quality and for the
performance of Pharmaceutical Quality System”
[ICH - Q10]
he first ever intent of developing standards was nothing but to avoid mix up of different ingredients or
process materials in manufacturing operations. No matter how experienced you are, how sincere you
are, how intelligent you are, you may come across with the smallest error of mix up that may sometimes
end up with horrible consequences. The reason of Punjab Institute of Cardiology (Lahore, Pakistan) tragedy in
year 2011 was nothing but a small innocent mix up that cost lives of hundreds of people. Good Manufacturing
Practices elements, its system to integrate operations and smart indicators to catch strength and sustainability of
Quality Management are not a choice, but an indispensible obligation. It is not incorrect that nothing can be down
to zero or below zero but moving from doable to desirable is the sign of life and proof of commitment with
quality. Quality Risk Management, Dashboard of Quality Metrics and culture of Data Integrity drive on the path
where information is transformed into knowledge and thus makes strategy of control stronger.
Wrongly identifying one material as “X” instead of “Y” in pharmaceutical manufacturing industry can never be
believed as a plan but may happen mainly due to bad judgment or lack of attention or poor communication among
personnel. Other possible reasons may be as under:
 Poor control on location of different materials that look similar
 Poor control during dispensing and re-packaging
 Simultaneous handling of multiple materials
 Poor control on un-used labels
 Offsite documentation
 Poor control on rejections stay, storage and destruction
 One printer for multiple computers working simultaneously
 One person performing two different jobs simultaneously
 Materials packaging having same color or combination of colors or dress
 One facility for multiple products with poor physical controls and clearance oversight
 Placement of different in-process materials in one room e.g. sterile and non-sterile
Thank you of reading, your comments and critics will be acknowledged and appreciated. Please write
at rooahama@gmail.com.
T

Weitere ähnliche Inhalte

Ähnlich wie Mix up Potential; A Dead End in Multiple Drug Manufacturing Facility

Quality Perspective of ‘Good Distribution Practices’ in Indian Pharmaceutical...
Quality Perspective of ‘Good Distribution Practices’ in Indian Pharmaceutical...Quality Perspective of ‘Good Distribution Practices’ in Indian Pharmaceutical...
Quality Perspective of ‘Good Distribution Practices’ in Indian Pharmaceutical...
iosrjce
 
Creating a roadmap to clinical trial efficiency
Creating a roadmap to clinical trial efficiencyCreating a roadmap to clinical trial efficiency
Creating a roadmap to clinical trial efficiency
Subhash Chandra
 

Ähnlich wie Mix up Potential; A Dead End in Multiple Drug Manufacturing Facility (20)

Confidence on Generics.pdf
Confidence on Generics.pdfConfidence on Generics.pdf
Confidence on Generics.pdf
 
Good Regulators of Pharmaceuticals (GRP) 22 October 2014
Good Regulators of Pharmaceuticals (GRP) 22 October 2014Good Regulators of Pharmaceuticals (GRP) 22 October 2014
Good Regulators of Pharmaceuticals (GRP) 22 October 2014
 
Pharmaceutical Quality - The Office of
Pharmaceutical Quality -  The Office ofPharmaceutical Quality -  The Office of
Pharmaceutical Quality - The Office of
 
5 of 5 Quality Metrics & Science by Obaid Ali
5 of 5  Quality Metrics & Science by Obaid Ali5 of 5  Quality Metrics & Science by Obaid Ali
5 of 5 Quality Metrics & Science by Obaid Ali
 
Clinical Trials Summit 2015
Clinical Trials Summit 2015Clinical Trials Summit 2015
Clinical Trials Summit 2015
 
6th annual clinical trials summit 2015
6th annual clinical trials summit 20156th annual clinical trials summit 2015
6th annual clinical trials summit 2015
 
Exec Brief
Exec Brief Exec Brief
Exec Brief
 
Generic Drug Performance
Generic Drug PerformanceGeneric Drug Performance
Generic Drug Performance
 
Pharma Asia Newsletter Launched
Pharma Asia Newsletter LaunchedPharma Asia Newsletter Launched
Pharma Asia Newsletter Launched
 
National Association of Healthcare Access Management Presentation
National Association of Healthcare Access Management PresentationNational Association of Healthcare Access Management Presentation
National Association of Healthcare Access Management Presentation
 
Pharmaceutical Quality Assurance in the 21st Century, Sharper Focus Needed on...
Pharmaceutical Quality Assurance in the 21st Century, Sharper Focus Needed on...Pharmaceutical Quality Assurance in the 21st Century, Sharper Focus Needed on...
Pharmaceutical Quality Assurance in the 21st Century, Sharper Focus Needed on...
 
Quality Perspective of ‘Good Distribution Practices’ in Indian Pharmaceutical...
Quality Perspective of ‘Good Distribution Practices’ in Indian Pharmaceutical...Quality Perspective of ‘Good Distribution Practices’ in Indian Pharmaceutical...
Quality Perspective of ‘Good Distribution Practices’ in Indian Pharmaceutical...
 
IGPA Building a Culture of Quality Ajaz Hussain_5 Sept 2015_Rferences min
IGPA Building a Culture of Quality Ajaz Hussain_5 Sept 2015_Rferences minIGPA Building a Culture of Quality Ajaz Hussain_5 Sept 2015_Rferences min
IGPA Building a Culture of Quality Ajaz Hussain_5 Sept 2015_Rferences min
 
CCK Dashboard 2019: Shape Knowledge to Navigate Future
CCK Dashboard 2019: Shape Knowledge to Navigate FutureCCK Dashboard 2019: Shape Knowledge to Navigate Future
CCK Dashboard 2019: Shape Knowledge to Navigate Future
 
Chemometrics Pharmacometrics Econometrics of QbD Swiss Pharma-6 2012
Chemometrics Pharmacometrics Econometrics of QbD Swiss Pharma-6 2012Chemometrics Pharmacometrics Econometrics of QbD Swiss Pharma-6 2012
Chemometrics Pharmacometrics Econometrics of QbD Swiss Pharma-6 2012
 
A Talk on Pharmaceutical Quality
A Talk on Pharmaceutical QualityA Talk on Pharmaceutical Quality
A Talk on Pharmaceutical Quality
 
Recent advances in pharmaceutical industry
Recent advances in pharmaceutical industryRecent advances in pharmaceutical industry
Recent advances in pharmaceutical industry
 
2015 Dashboard of Pharmaceutical & Biologics Regulatory Sciences
2015 Dashboard of Pharmaceutical & Biologics Regulatory Sciences2015 Dashboard of Pharmaceutical & Biologics Regulatory Sciences
2015 Dashboard of Pharmaceutical & Biologics Regulatory Sciences
 
Creating a roadmap to clinical trial efficiency
Creating a roadmap to clinical trial efficiencyCreating a roadmap to clinical trial efficiency
Creating a roadmap to clinical trial efficiency
 
TQM
TQMTQM
TQM
 

Mehr von Obaid Ali / Roohi B. Obaid

Mehr von Obaid Ali / Roohi B. Obaid (20)

A Strategic Talk on Biologicals & Biotechnological Products
A Strategic Talk on Biologicals & Biotechnological ProductsA Strategic Talk on Biologicals & Biotechnological Products
A Strategic Talk on Biologicals & Biotechnological Products
 
A Tragic Resistance to Learn.pdf
A Tragic Resistance to Learn.pdfA Tragic Resistance to Learn.pdf
A Tragic Resistance to Learn.pdf
 
230930.pdf
230930.pdf230930.pdf
230930.pdf
 
Demonstrate your QMS during Inspection-30 Sep 2023.pdf
Demonstrate your QMS during Inspection-30 Sep 2023.pdfDemonstrate your QMS during Inspection-30 Sep 2023.pdf
Demonstrate your QMS during Inspection-30 Sep 2023.pdf
 
Centre for Quality Sciences-2023
Centre for Quality Sciences-2023Centre for Quality Sciences-2023
Centre for Quality Sciences-2023
 
Track, Trace & Understand Science of Life from Real World Evidence.pdf
Track, Trace & Understand Science of Life from Real World Evidence.pdfTrack, Trace & Understand Science of Life from Real World Evidence.pdf
Track, Trace & Understand Science of Life from Real World Evidence.pdf
 
Neurotoxicity & Neurodegenaration.pdf
Neurotoxicity & Neurodegenaration.pdfNeurotoxicity & Neurodegenaration.pdf
Neurotoxicity & Neurodegenaration.pdf
 
Application of Data & AI in Pharma 4
Application of Data & AI in Pharma 4Application of Data & AI in Pharma 4
Application of Data & AI in Pharma 4
 
PICS-ICH
PICS-ICHPICS-ICH
PICS-ICH
 
Quality Affairs of Pharmaceuticals
Quality Affairs of PharmaceuticalsQuality Affairs of Pharmaceuticals
Quality Affairs of Pharmaceuticals
 
120th Training Session - Unfortunate Wave of DEG Tragedy.pdf
120th Training Session - Unfortunate Wave of DEG Tragedy.pdf120th Training Session - Unfortunate Wave of DEG Tragedy.pdf
120th Training Session - Unfortunate Wave of DEG Tragedy.pdf
 
CQS Session - RO - 16 Oct 2022.pdf
CQS Session - RO - 16 Oct 2022.pdfCQS Session - RO - 16 Oct 2022.pdf
CQS Session - RO - 16 Oct 2022.pdf
 
GMP Session for Professional Development.pdf
GMP Session for Professional Development.pdfGMP Session for Professional Development.pdf
GMP Session for Professional Development.pdf
 
Q & A - June - Sep 2022.pdf
Q & A - June - Sep 2022.pdfQ & A - June - Sep 2022.pdf
Q & A - June - Sep 2022.pdf
 
Judging Science & Prior Knowledge Beyond the Line
Judging Science & Prior Knowledge Beyond the LineJudging Science & Prior Knowledge Beyond the Line
Judging Science & Prior Knowledge Beyond the Line
 
Maturing Drug Quality to Deliver Promise
Maturing Drug Quality to Deliver PromiseMaturing Drug Quality to Deliver Promise
Maturing Drug Quality to Deliver Promise
 
PQRS 2022 - Education
PQRS  2022 - EducationPQRS  2022 - Education
PQRS 2022 - Education
 
4 - GMP June 2022 - CQS.pdf
4 - GMP June 2022 - CQS.pdf4 - GMP June 2022 - CQS.pdf
4 - GMP June 2022 - CQS.pdf
 
3 - GMP June 2022 - CQS.pdf
3 - GMP June 2022 - CQS.pdf3 - GMP June 2022 - CQS.pdf
3 - GMP June 2022 - CQS.pdf
 
2 - GMP June 2022 - CQS.pdf
2 - GMP June 2022 - CQS.pdf2 - GMP June 2022 - CQS.pdf
2 - GMP June 2022 - CQS.pdf
 

Kürzlich hochgeladen

Abortion pills in Jeddah |• +966572737505 ] GET CYTOTEC
Abortion pills in Jeddah |• +966572737505 ] GET CYTOTECAbortion pills in Jeddah |• +966572737505 ] GET CYTOTEC
Abortion pills in Jeddah |• +966572737505 ] GET CYTOTEC
Abortion pills in Riyadh +966572737505 get cytotec
 
Agile Coaching Change Management Framework.pptx
Agile Coaching Change Management Framework.pptxAgile Coaching Change Management Framework.pptx
Agile Coaching Change Management Framework.pptx
alinstan901
 
Beyond the Codes_Repositioning towards sustainable development
Beyond the Codes_Repositioning towards sustainable developmentBeyond the Codes_Repositioning towards sustainable development
Beyond the Codes_Repositioning towards sustainable development
Nimot Muili
 

Kürzlich hochgeladen (15)

Abortion pills in Jeddah |• +966572737505 ] GET CYTOTEC
Abortion pills in Jeddah |• +966572737505 ] GET CYTOTECAbortion pills in Jeddah |• +966572737505 ] GET CYTOTEC
Abortion pills in Jeddah |• +966572737505 ] GET CYTOTEC
 
Agile Coaching Change Management Framework.pptx
Agile Coaching Change Management Framework.pptxAgile Coaching Change Management Framework.pptx
Agile Coaching Change Management Framework.pptx
 
Dealing with Poor Performance - get the full picture from 3C Performance Mana...
Dealing with Poor Performance - get the full picture from 3C Performance Mana...Dealing with Poor Performance - get the full picture from 3C Performance Mana...
Dealing with Poor Performance - get the full picture from 3C Performance Mana...
 
Day 0- Bootcamp Roadmap for PLC Bootcamp
Day 0- Bootcamp Roadmap for PLC BootcampDay 0- Bootcamp Roadmap for PLC Bootcamp
Day 0- Bootcamp Roadmap for PLC Bootcamp
 
Call now : 9892124323 Nalasopara Beautiful Call Girls Vasai virar Best Call G...
Call now : 9892124323 Nalasopara Beautiful Call Girls Vasai virar Best Call G...Call now : 9892124323 Nalasopara Beautiful Call Girls Vasai virar Best Call G...
Call now : 9892124323 Nalasopara Beautiful Call Girls Vasai virar Best Call G...
 
International Ocean Transportation p.pdf
International Ocean Transportation p.pdfInternational Ocean Transportation p.pdf
International Ocean Transportation p.pdf
 
Call Now Pooja Mehta : 7738631006 Door Step Call Girls Rate 100% Satisfactio...
Call Now Pooja Mehta :  7738631006 Door Step Call Girls Rate 100% Satisfactio...Call Now Pooja Mehta :  7738631006 Door Step Call Girls Rate 100% Satisfactio...
Call Now Pooja Mehta : 7738631006 Door Step Call Girls Rate 100% Satisfactio...
 
Reviewing and summarization of university ranking system to.pptx
Reviewing and summarization of university ranking system  to.pptxReviewing and summarization of university ranking system  to.pptx
Reviewing and summarization of university ranking system to.pptx
 
Safety T fire missions army field Artillery
Safety T fire missions army field ArtillerySafety T fire missions army field Artillery
Safety T fire missions army field Artillery
 
BDSM⚡Call Girls in Sector 99 Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Sector 99 Noida Escorts >༒8448380779 Escort ServiceBDSM⚡Call Girls in Sector 99 Noida Escorts >༒8448380779 Escort Service
BDSM⚡Call Girls in Sector 99 Noida Escorts >༒8448380779 Escort Service
 
Intro_University_Ranking_Introduction.pptx
Intro_University_Ranking_Introduction.pptxIntro_University_Ranking_Introduction.pptx
Intro_University_Ranking_Introduction.pptx
 
Beyond the Codes_Repositioning towards sustainable development
Beyond the Codes_Repositioning towards sustainable developmentBeyond the Codes_Repositioning towards sustainable development
Beyond the Codes_Repositioning towards sustainable development
 
Strategic Management, Vision Mission, Internal Analsysis
Strategic Management, Vision Mission, Internal AnalsysisStrategic Management, Vision Mission, Internal Analsysis
Strategic Management, Vision Mission, Internal Analsysis
 
internal analysis on strategic management
internal analysis on strategic managementinternal analysis on strategic management
internal analysis on strategic management
 
GENUINE Babe,Call Girls IN Baderpur Delhi | +91-8377087607
GENUINE Babe,Call Girls IN Baderpur  Delhi | +91-8377087607GENUINE Babe,Call Girls IN Baderpur  Delhi | +91-8377087607
GENUINE Babe,Call Girls IN Baderpur Delhi | +91-8377087607
 

Mix up Potential; A Dead End in Multiple Drug Manufacturing Facility

  • 1. Where Attention & Judgment Saves from Catastrophe Mix up Potential; A Dead End in Multiple Drug Manufacturing Facility Roohi B. Obaid, R. Ph., M. Phil. Alumni CDER-USFDA & HPFB-Health Canada (Karachi the 04th Mar, 2018) “Leadership is essential to maintain a companywide commitment to quality and for the performance of Pharmaceutical Quality System” [ICH - Q10] he first ever intent of developing standards was nothing but to avoid mix up of different ingredients or process materials in manufacturing operations. No matter how experienced you are, how sincere you are, how intelligent you are, you may come across with the smallest error of mix up that may sometimes end up with horrible consequences. The reason of Punjab Institute of Cardiology (Lahore, Pakistan) tragedy in year 2011 was nothing but a small innocent mix up that cost lives of hundreds of people. Good Manufacturing Practices elements, its system to integrate operations and smart indicators to catch strength and sustainability of Quality Management are not a choice, but an indispensible obligation. It is not incorrect that nothing can be down to zero or below zero but moving from doable to desirable is the sign of life and proof of commitment with quality. Quality Risk Management, Dashboard of Quality Metrics and culture of Data Integrity drive on the path where information is transformed into knowledge and thus makes strategy of control stronger. Wrongly identifying one material as “X” instead of “Y” in pharmaceutical manufacturing industry can never be believed as a plan but may happen mainly due to bad judgment or lack of attention or poor communication among personnel. Other possible reasons may be as under:  Poor control on location of different materials that look similar  Poor control during dispensing and re-packaging  Simultaneous handling of multiple materials  Poor control on un-used labels  Offsite documentation  Poor control on rejections stay, storage and destruction  One printer for multiple computers working simultaneously  One person performing two different jobs simultaneously  Materials packaging having same color or combination of colors or dress  One facility for multiple products with poor physical controls and clearance oversight  Placement of different in-process materials in one room e.g. sterile and non-sterile Thank you of reading, your comments and critics will be acknowledged and appreciated. Please write at rooahama@gmail.com. T